Global expansion Codis is expanding its European footprint through acquisitions and facility expansions, including the Nottingham assets, creating Europe’s leading end-to-end spray drying capability. This signals growing demand for scaled, integrated CDMO services in Europe and opportunities to engage with multinational pharma players seeking seamless cross-border manufacturing.

Spray drying leadership Codis focuses on commercial spray drying, amorphous solid dispersions and particle engineering, positioning as a specialist partner for clients needing high-performance formulations. This presents cross-sell opportunities with companies looking to convert solid dispersions or optimize bioavailability in late-stage development and commercial launches.

Private funding momentum Recent growth investments from 1315 Capital and participation from BroadOak and RCT indicate strong financial backing and a growth trajectory. This can be leveraged to approach life sciences teams with ambitious development pipelines seeking reliable capital-backed CDMO partnerships for scale-up and commercialization.

Regulatory capability Codis highlights proven regulatory performance alongside technical expertise, suggesting reliability for projects requiring stringent compliance and scale. Engage with QA/Reg affairs and global supply chain leads seeking a partner with robust regulatory track record for complex spray-dried products.

Strategic leadership New senior leadership appointments for the Haverhill facility and ongoing sales & marketing expansion signal a focus on customer acquisition and market penetration. This creates opportunities to connect with decision-makers in sales, marketing and operations at potential client accounts looking for proactive, customer-focused CDMO relationships.